Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes. (Q50789643)

19 March 2018

title

Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes. (English)

1 reference

19 March 2018

0 references

4

1 reference

19 March 2018

Vanessa Zambelli

5

1 reference

19 March 2018

Giuseppe Remuzzi

11

1 reference

19 March 2018

Ariela Benigni

Ariela Benigni

12

0 references

Daniela Corna

7

Daniela Corna

1 reference

19 March 2018

Carla Zoja

1

Carla Zoja

1 reference

19 March 2018

Monica Salio

6

Monica Salio

1 reference

19 March 2018

Daniela Rottoli

9

Daniela Rottoli

1 reference

19 March 2018

Sara Cattaneo

2

Sara Cattaneo

1 reference

19 March 2018

author name string

Fabio Fiordaliso

3

1 reference

19 March 2018

Chiara Pagani

8

1 reference

19 March 2018

Cinzia Bisighini

10

1 reference

19 March 2018

publication date

3 August 2011

1 reference

19 March 2018

American Journal of Physiology - Renal Physiology

published in

1 reference

19 March 2018

volume

301

1 reference

19 March 2018

page(s)

F1114-23

1 reference

19 March 2018

issue

5

1 reference

19 March 2018

How does proteinuria cause progressive renal damage?

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Peroxisome Proliferator-Activated Receptor γ Agonist Provides Superior Renal Protection versus Angiotensin-Converting Enzyme Inhibition in a Rat Model of Type 2 Diabetes with Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Disruption of the Ang II type 1 receptor promotes longevity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Distal degenerative sensory neuropathy in a long-term type 2 diabetes rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Rodent models of diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Increased activity of endogenous endothelin in patients with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Cardiac carbohydrate metabolism in Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-no pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

ET(A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

New therapeutics that antagonize endothelin: promises and frustrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Preventing microalbuminuria in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Time to abandon microalbuminuria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Renal protective effect of YM598, a selective endothelin type A receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Exaggerated vascular and renal pathology in endothelin-B-receptor-deficient rats with subtotal nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Detection of specific nitrotyrosine-modified proteins as a marker of oxidative stress in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00122.2011

10.1152/AJPRENAL.00122.2011

21 January 2018

Identifiers

DOI

1 reference

19 March 2018

PubMed ID

21816757

1 reference

19 March 2018